Related Experiment Video
Updated: May 20, 2025

10:13
Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
Published on: February 14, 2014
13.6K
A description of processing speed, learning and memory in people with multiple sclerosis aged 55
Sharon Lynch1, Sara Baker1, Muhammad Nashatizadeh1
1Department of Neurology, University of Kansas Medical Center, 3901 Rainbow BLVD, Kansas City, KS, 66160, USA.
Multiple Sclerosis and Related Disorders
|April 22, 2025
Summary
Older adults with Multiple Sclerosis (MS) experience worse cognitive function, particularly in processing speed and memory. However, the rate of age-related cognitive decline is similar in people with MS and those without.
Area of Science:
- Neuroscience
- Cognitive Science
- Neurology
Background:
- Multiple Sclerosis (MS) frequently causes cognitive impairments affecting executive function, attention, memory, and processing speed.
- Cognitive decline is a natural part of aging, but its accelerated progression in people with MS (pwMS) remains unclear.
Purpose of the Study:
- To evaluate information processing speed, memory, and learning in an older cohort of pwMS.
- To investigate the influence of polypharmacy and age-related comorbidities on cognitive function in pwMS.
Main Methods:
- Ninety-nine participants aged 55+ with and without MS were assessed.
- Cognitive function was measured using the Brief International Cognitive Assessment for Multiple Sclerosis.
- Polypharmacy, medication burden (anticholinergic, sedative), and comorbidities were evaluated.
Main Results:
- Older pwMS showed significantly poorer performance in information processing speed, learning, and delayed recall compared to people without MS (p<0.01), after controlling for age, gender, and education.
- The rate of age-related cognitive decline was comparable between pwMS and people without MS.
Conclusions:
- PwMS in this study exhibited diminished cognitive function relative to non-neurologic controls.
- Advancing age appears to affect cognitive function similarly in both people with MS and those without MS.

